Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and p… Read more
Nephros Inc - Asset Resilience Ratio
Nephros Inc (NEPH) has an Asset Resilience Ratio of 0.56% as of March 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2004–2018)
This chart shows how Nephros Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Nephros Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $26.00K | 0.56% |
| Total Liquid Assets | $26.00K | 0.56% |
Asset Resilience Insights
- Limited Liquidity: Nephros Inc maintains only 0.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Nephros Inc Industry Peers by Asset Resilience Ratio
Compare Nephros Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for Nephros Inc (2004–2018)
The table below shows the annual Asset Resilience Ratio data for Nephros Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $10.56 Million | -- |
| 2017-12-31 | 0.40% | $20.00K | $4.98 Million | -0.61pp |
| 2016-12-31 | 1.01% | $27.00K | $2.68 Million | +0.83pp |
| 2008-12-31 | 0.17% | $7.00K | $4.04 Million | -46.43pp |
| 2007-12-31 | 46.60% | $4.70 Million | $10.09 Million | -7.59pp |
| 2006-12-31 | 54.19% | $2.80 Million | $5.17 Million | -3.32pp |
| 2005-12-31 | 57.51% | $4.50 Million | $7.82 Million | +8.39pp |
| 2004-12-31 | 49.12% | $6.00 Million | $12.21 Million | -- |